U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Development & Approval Process | Drugs
  4. Development Resources
  5. Cefprozil – Oral products
  1. Development Resources

Cefprozil – Oral products

Exceptions to the recognized standard of CLSI M100

 Minimum Inhibitory
Concentrations
(mcg/mL)
Disk Diffusion
(zone diameter in mm)
PathogenSIRSIR
Streptococcus pneumoniae≤0.5-≥1---

S = Susceptible; I = Intermediate; R = Resistant
Susceptibility interpretive criteria for microorganisms are based on a dosing regimen of 500 mg q12h (adults) or 15 mg/kg q12h (pediatrics)

For the bacteria listed below, susceptibility test interpretive criteria are not recognized at this time:

Haemophilus influenzae and parainfluenzae

Enterobacteriaceae